冷冻消融与射频消融术后心房颤动进展:CIRCA-DOSE试验
射频消融与更少的持续性房颤进展相关。
要点
- 射频消融组无持续性房性快速性心律失常进展,冷冻球囊组发生率为4.3%-7.0%。
- 三组房性快速性心律失常复发率(≥30秒)和房颤负荷降低幅度无显著差异。
- 对于药物难治性阵发性房颤,射频消融可能减少进展为持续性房颤的风险。
核心结论
- 射频消融治疗阵发性房颤与随访期间更少的持续性房颤进展相关。
临床怎么用
- 在药物难治性阵发性房颤患者中选择消融能量时,可考虑射频消融以降低进展为持续性房颤的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Atrial fibrillation (AF) is a chronic progressive disorder. Persistent forms of AF are associated with increased rates of thromboembolism, heart failure, and death. Catheter ablation modifies the pathogenic mechanism of AF progression. No randomized studies have evaluated the impact of the ablation energy on progression to persistent atrial tachyarrhythmia. METHODS: Three hundred forty-six patients with drug-refractory paroxysmal AF were enrolled and randomly assigned to contact-force-guided RF ablation (CF-RF ablation, 115), 4 min cryoballoon ablation (CRYO-4, 115), or 2 min cryoballoon ablation (CRYO-2, 116). Implantable cardiac monitors placed at study entry were used for follow-up. The main outcome was the first episode of persistent atrial tachyarrhythmia. Secondary outcomes included atrial tachyarrhythmia recurrence and arrhythmia burden on the implantable monitor. RESULTS: At a median of 944.0 (interquartile range [IQR], 612.5-1104) days, 0 of 115 patients (0.0%) randomly assigned to CF-RF, 8 of 115 patients (7.0%) assigned to CRYO-4, and 5 of 116 patients (4.3%) assigned to CRYO-2 experienced an episode of persistent atrial tachyarrhythmia (P = .03). A documented recurrence of any atrial tachyarrhythmia ≥30 s occurred in 56.5%, 53.9%, and 62.9% of those randomized to CF-RF, CRYO-4, and CRYO-2, respectively; P = .65. Compared with that of the pre-ablation monitoring period, AF burden was reduced by a median of 99.5% (IQR 94.0%, 100.0%) with CF-RF, 99.9% (IQR 93.3%-100.0%) with CRYO-4, and 99.1%% (IQR 87.0%-100.0%) with CRYO-2 (P = .38). CONCLUSIONS: Catheter ablation of paroxysmal AF using radiofrequency energy was associated with fewer patients developing persistent AF on follow-up.
引用
- Andrade JG, Deyell MW, Khairy P, et al. Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial. Eur Heart J. 2024. PMID: 37624879. doi:10.1093/eurheartj/ehad572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。